Clinical Trial Update: Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy [NA]

View source ↗

Summary

A completed clinical trial evaluated parotid-gland stem-cell sparing intensity-modulated radiotherapy for head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Head and Neck Cancer | NA | Status: COMPLETED